High prices, lack of equipment hampering AIDS diagnosis
This article was originally published in Clinica
The lack of an effective, reliable supply of diagnostics is at the heart of the global war on AIDS. This is irrespective of the huge increases in funding being made available by governments and charitable organisations alike, as the epidemic continues to outrun incidence predictions.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.